Dr. Hubert Birner is Chairman at Argos Therapeutics, Inc., Managing Partner at TVM Capital GmbH, Managing Partner at TVM Life Science Management GmbH, and Chairman at NOXXON Pharma AG.
He is on the Board of Directors at Probiodrug AG and Proteon Therapeutics, Inc.
Dr. Birner was previously employed as Independent Director by Horizon Pharma, Inc., a Member-Supervisory Board by Evotec AG, Chairman-Supervisory Board by Jerini AG, Chairman-Supervisory Board by DIREVO Biotech AG, Head-European Business Development by Zeneca Agrochemicals, and Marketing Director by Zeneca Group Plc.
He also served on the board at Nitec Pharma AG, TransMolecular, Inc., BioXell SpA, and SpePharm Holding BV.
He received his MBA from Harvard Business School and a doctorate degree from Ludwig-Maximilians-Universität München.